Page results
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
-
London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
Dr Katherine Clesham is a consultant haematologist specialising in the treatment of teenagers and young adults with acute leukaemia and patients undergoing stem cell transplantation and CAR-T therapy.
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
-
The spasticity team at The National Hospital for Neurology and Neurosurgery (NHNN) has produced a series of short animated videos. The films were funded by The National Brain Appeal, the charity dedicated to supporting NHNN.
-
A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.
-
UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
File results
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0412 - Healthcare travel costs scheme for patients